HMGA2 and thyroid gland carcinoma: Despite its high specificity for malignant tumors, HMGA2 upregulation is characteristic only of thyroid carcinoma deriving from follicular cells, not from Hürthle and parafollicular cells; this state of affairs affects its diagnostic sensitivity and NPV when the HMGA2 expression level serves as a molecular marker of malignancy.